CompletedNCT05655754
Comparing anesthesia medicines used during electroconvulsive therapy
About this title
Read the official source — NCT05655754Medication studyAges 18+AustriaDepression
Understand this study
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- ViennaSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateStarted: November 1, 2022
- Recruitment status
- Completed
- Enrollment listed in the registry
- 56
- Sponsor
- Medical University of Vienna
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Austria
- Age range
- Over 18 Years
- Official registry ID
- NCT05655754
- Official title
Show the full official title
A Prospective Randomized, Double Blind, Controlled, Safety and Non-inferiority Study of Esketamine Plus Propofol Compared to Methohexital Anesthesia for Electroconvulsive Therapy
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Vienna
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Medical University of Vienna, a university.
Did this study involve medication?
Yes. The study involved medication, including Methohexital and Ketofol.
Who was this study for?
Listed age limits: from 18 years.
